Cefzil and Photosensitivity reaction - a phase IV clinical study of FDA data

Summary:

Photosensitivity reaction is reported only by a few people who take Cefzil.

The phase IV clinical study analyzes which people take Cefzil and have Photosensitivity reaction. It is created by eHealthMe based on reports of 1,074 people who have side effects while taking Cefzil from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 09, 2023

1,074 people reported to have side effects when taking Cefzil.
Among them, 2 people (0.19%) have Photosensitivity reaction.

What is Cefzil?

Cefzil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,083 Cefzil users for its effectiveness, alternative drugs and more.

What is Photosensitivity reaction?

Photosensitivity reaction is found to be associated with 2,041 drugs and 1,234 conditions by eHealthMe.

Number of Cefzil and Photosensitivity reaction reports submitted per year:

Could Cefzil cause Photosensitivity reaction?

Gender of people who have Photosensitivity reaction when taking Cefzil *:

female: 50 %
male: 50 %

Age of people who have Photosensitivity reaction when taking Cefzil *:

Common drugs people take besides Cefzil *:

Common side effects people have besides Photosensitivity reaction *:

Weakness: 1 person, 50.00%
Itching: 1 person, 50.00%
Interstitial Lung Disease: 1 person, 50.00%
Infection In An Immunocompromised Host: 1 person, 50.00%
Hypotension (abnormally low blood pressure): 1 person, 50.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 50.00%
Enlarged Heart: 1 person, 50.00%
Dehydration (dryness resulting from the removal of water): 1 person, 50.00%
Complement Factor C3 Increased: 1 person, 50.00%
Cells In Urine: 1 person, 50.00%

Common conditions people have *:

Psoriasis (immune-mediated disease that affects the skin): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefzil and have Photosensitivity reaction?

Check whether Photosensitivity reaction is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
Kocamaz, M., & Karadag, O., "Topiramate-Induced Acute Myopia, Diplopia, and Photosensitivity: A Case Report", Beyoglu Eye Journal, 2019 Jan .

Related studies

How severe was Photosensitivity reaction and when was it recovered:

Photosensitivity reaction in Cefzil

Expand to all the drugs that have ingredients of cefprozil:

Photosensitivity reaction and drugs with ingredients of cefprozil (2 reports)

Alternative drugs to, pros and cons of Cefzil:

Cefzil (1,083 reports)

Photosensitivity reaction treatments and more:

Photosensitivity reaction (16,491 reports)

COVID vaccines that are related to Photosensitivity reaction:

Common drugs associated with Photosensitivity reaction:

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefzil) and Cefzil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.